Baxter International Inc. vs Johnson & Johnson — Stock Comparison

BAX
Baxter International Inc.
$17.21
▼ 2.10%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 4.8/10

Q·Score Breakdown

4.8
Bearish
Overall
7.1
Bullish
3.8
Quality
9.3
4.5
Health
6.5
4.7
Growth
5.1
7.1
Valuation
7.3
4
Sentiment
6.5
BAX

Consensus analyst target of $22.12 is 29% above current price.

currently unprofitable (-10% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $22.12 (+28.5%)
13 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

BAX
JNJ
Trailing P/E
26.3×
8.5×
Forward P/E
17.9×
-9.7%
Profit Margin
21.8%
34.6%
Gross Margin
68.0%
ROE
26.4%
2.9%
Revenue Growth
9.9%
Earnings Growth
-52.9%
0.62
Beta
0.33
Price / Book
$8.9B
Market Cap
$546.9B
$16 – $33
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →